Published in J Neurochem on March 01, 1972
Norepinephrine induces glial-specific enzyme activity in cultured plasma glioma cells. Proc Natl Acad Sci U S A (1977) 1.33
Ganglioside content and pattern in human gliomas in culture. Correlation of morphological changes with altered gangliosides. Acta Neuropathol (1977) 0.85
Galactocerebroside is expressed by non-myelin-forming Schwann cells in situ. J Cell Biol (1985) 0.83
Lipid metabolism of isolated oligodendrocytes maintained in long-term culture mimics events associated with myelinogenesis. Proc Natl Acad Sci U S A (1983) 0.81
The incorporation of radioactive fatty acids into the phospholipids of nerve-cell-body membranes in vivo. Biochem J (1980) 0.75
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science (1973) 2.91
Isolation of filaments from brain. Science (1971) 2.03
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97
The cytoskeleton of primary astrocytes in culture contains actin, glial fibrillary acidic protein, and the fibroblast-type filament protein, vimentin. J Neurochem (1981) 1.79
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol (1991) 1.73
Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol (1990) 1.71
The lipid composition of purified bovine brain myelin. J Neurochem (1966) 1.62
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
Axons: isolation from mammalian central nervous system. Science (1972) 1.55
Isolation of myelin from nerve tissue. Methods Enzymol (1974) 1.35
Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol (1976) 1.29
Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol (1966) 1.24
Quaking mouse: isolation and characterization of myelin protein. J Neurochem (1971) 1.22
Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J Neurochem (1982) 1.19
Neuronal soma and whole neuroglia of rat brain: a new isolation technique. Science (1970) 1.11
Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds. Glia (1996) 1.06
The cardiac sodium channel mRNA is expressed in the developing and adult rat and human brain. Brain Res (2000) 1.05
Intermediate filaments from bovine, rat, and human CNS: mapping analysis of the major proteins. J Neurochem (1980) 1.05
Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature (1980) 1.04
Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol (1993) 1.04
Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet (2007) 1.03
Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab Invest (1984) 1.02
Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci (1996) 0.98
The fatty acid composition of sphingolipids from bovine CNS axons and myelin. J Neurochem (1974) 0.97
Prazosin treatment suppresses increased vascular permeability in both acute and passively transferred experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol (1986) 0.95
The characterization of sphingolipids from neurons and astroglia of immature rat brain. J Neurochem (1974) 0.95
Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol (1989) 0.94
Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells. Differentiation (1992) 0.94
Augmentation of immune-mediated demyelination by lipid haptens. Lab Invest (1981) 0.93
Neuronal perikarya and astroglia of rat brain: chemical composition during myelination. J Lipid Res (1971) 0.93
The lipid composition of isolated brain cells and axons. J Neurosci Res (1975) 0.92
CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet (2006) 0.91
Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim Biophys Acta (1968) 0.91
Utilization of ketone bodies and glucose by established neural cell lines. J Neurosci Res (1982) 0.91
Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Proc Natl Acad Sci U S A (1985) 0.90
Biochemical and pathological studies of myelin in hexachlorophene intoxication. Brain Res (1975) 0.90
Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalomyelitis. J Neurochem (1988) 0.89
Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin. J Neuropathol Exp Neurol (1997) 0.88
Myelin. Sci Am (1980) 0.88
Differential expression of isoforms of the regulatory subunit of type II cAMP-dependent protein kinase in rat neurons, astrocytes, and oligodendrocytes. J Biol Chem (1987) 0.88
5'-nucleotidase in rat brain myelin. J Neurochem (1980) 0.88
Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease. J Med Genet (2005) 0.88
The isolation and characterization of a plasma membrane and a myelin fraction derived from oligodendroglia of calf brain. J Neurochem (1975) 0.87
Gangliosides in the myelin fraction of developing rats. Biochim Biophys Acta (1967) 0.87
A modified procedure for isolation of astrocyte- and neuron-enriched fractions from rat brain. J Neurochem (1978) 0.87
Cystatin C as a risk factor for Alzheimer disease. Neurology (2005) 0.87
Biochemical and immunocytochemical changes in glial fibrillary acidic protein after stab wounds. Brain Res (1990) 0.87
Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol (1986) 0.86
Biochemistry of demyelination. Brain Pathol (1996) 0.86
The ultrastructure of purified preparations of neurons and glial cells. Brain Res (1971) 0.85
Neurofilaments account for the lipid in myelin-free axons. Brain Res (1976) 0.85
Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination. Brain Res (1986) 0.85
Tumor necrosis factor-induced proliferation of astrocytes from mature brain is associated with down-regulation of glial fibrillary acidic protein mRNA. J Neurochem (1991) 0.84
Disc gel electrophoresis of myelin proteins: new observations on development of the intermediate proteins (DM-20). Brain Res (1976) 0.84
High-performance implementation and analysis of the Linkmap program. J Biomed Inform (2001) 0.83
Isolation of specific brain cells. Methods Enzymol (1975) 0.83
Biochemistry of myelin. Adv Neurol (1981) 0.83
On the parallelization of linkmap from the LINKAGE/FASTLINK package. Comput Biomed Res (2000) 0.83
Expression of glial fibrillary acidic protein and neurofilament mRNA in gliosis induced by experimental autoimmune encephalomyelitis. J Neurochem (1990) 0.83
Purification of proteolipid protein and production of specific antiserum. J Neuroimmunol (1986) 0.82
The long term culture of bulk-isolated bovine oligodendroglia from adult brain. Brain Res (1983) 0.82
Brain carbonic anhydrase: activity in isolated myelin and the effect of hexachlorophene. J Neurochem (1976) 0.82
Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem Res (1997) 0.82
Metabolic properties of maintained oligodendroglia purified from brain. J Biol Chem (1978) 0.82
Degradation of the P0, P1, and Pr proteins in peripheral nervous system myelin by plasmin: implications regarding the role of macrophages in demyelinating diseases. J Neurochem (1981) 0.82
The bulk isolation of oligodendroglia from whole rat forebrain: a new procedure using physiologic media. J Neurochem (1980) 0.82
The isolation of cerebral neurons with partial retention of processes. Brain Res (1977) 0.82
Myelin development in infant brain. Neurochem Res (1984) 0.82
Biochemical studies of metachromatic leukodystrophy in three siblings. Acta Neuropathol (1982) 0.82
Biochemical studies of the late infantile form of metachromatic leukodystrophy. Acta Neuropathol (1982) 0.81
The production of a membrane by purified oligodendroglia maintained in culture. Exp Cell Res (1982) 0.81
Light-scattering patterns of isolated oligodendroglia. J Histochem Cytochem (1974) 0.81
Recent advances in myelin biochemistry. Ann N Y Acad Sci (1984) 0.80
The effect of reducing agents on the apparent molecular weight of the myelin P0 protein and the possible identity of the P0 and "Y" proteins. J Neurochem (1980) 0.80
Comparisons of proteins and glycoproteins in neuronal plasma membranes, axolemma, synaptic membranes, and oligodendroglial plasma membranes. J Neurosci Res (1987) 0.80
The 70-kDa heat shock cognate protein (HSC70) is a major constituent of the central nervous system and is up-regulated only at the mRNA level in acute experimental autoimmune encephalomyelitis. J Neurochem (1993) 0.79
Comparison of lipids and lipid metabolism in a human glioma cell line, its clone, and oligodendroglia. Cancer Res (1983) 0.79
The characterization of sphingolipids of oligodendroglia from calf brain. J Neurochem (1979) 0.79
Cluster analysis of risk factor genetic polymorphisms in Alzheimer's disease. Neurochem Res (2008) 0.79
Purification and maintenance in culture of oligodendroglia from human multiple sclerosis brain. J Neurol Sci (1982) 0.79
Antiserums to neurons and to oligodendroglia from mammalian brain. Science (1977) 0.79
Maintenance of neurons isolated in bulk from rat brain: incorporation of radiolabeled substrates. Brain Res (1977) 0.78
Ketone body enzyme activities in purified neurons, astrocytes and oligodendroglia. Neurochem Int (1987) 0.78
Properties of bovine oligodendroglia isolated by a new procedure using physiologic conditions. J Neurochem (1981) 0.78
Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue. J Neuropathol Exp Neurol (1977) 0.78
Activities of glycolipid hydrolases in neurons and astroglia from rat and calf brains and in oligodendroglia from calf brain. Brain Res (1979) 0.78
Encephalitogenic properties of purified preparations of bovine oligodendrocytes tested in guinea pigs. Brain Res (1978) 0.78
A comparison of the glycoproteins and the proteins from multiple sclerosis and normal brain tissue. Neurochem Res (1986) 0.78